Difference between revisions of "Team:NCTU Formosa/Overview"

Line 43: Line 43:
 
left:0vw;
 
left:0vw;
 
background-repeat:no-repeat;
 
background-repeat:no-repeat;
−
background-size:100%;
+
background-size:90%;
 
}
 
}
 
.content1{
 
.content1{
Line 76: Line 76:
 
background-repeat:no-repeat;
 
background-repeat:no-repeat;
 
background-position:center;
 
background-position:center;
−
background-size:70%;
+
background-size:80%;
 
}
 
}
 
.photo4{
 
.photo4{

Revision as of 14:54, 2 September 2015

The Brand-New Diagnosis Era
With our hit product, we provide the convenient and efficient diagnosis for prescribing personalized targeted drug therapy via tissue biopsies. To achieve this promising goal, the APOllO E.Cotector not only displays single chain variable fragment (scFv) which are directly from monoclonal antibody targeted drugs as probes to detect specific biomarkers, but also simultaneously expresses the florescent protein as signal for instant observation. Furthermore, by changing various kinds of scFv on the surfaces of E.Cotectors, it can identify multimarker and suggest physicians the prescription of combination and personalised therapy.
To provide an alternative method of pre-diagnosis, APOllO E.Cotector Plus can not only display scFv but also able immobilize on gold surface. It can be applied on high-tech measurement machine which uses gold as signal transducer. Via the combination of various microbalances, APOllO E.Cotector Plus can truly determine the quantity of cancer antigens in serum.
It can provide a cross comparison with tissue biopsies and provide doctors more details about cancer patients' condition.
contact us
NCTU_Formosa APOllO   
  Engineering Building 6 EF455, 1001 University Road, Hsinchu 300, Taiwan, ROC.